Ahmadian
Freshteh Ahmadian, Reno, NV US
| Patent application number | Description | Published |
|---|---|---|
| 20090218136 | WATER BOTTOM ORE SAMPLER AND METHOD OF USING THE SAME - A water bottom ore sampler includes a submersible housing for positioning on or near a water bottom, a riser duct mounted within the submersible housing and movable vertically relative to the submersible housing, a drilling assembly disposed within the riser duct for excavating the water bottom, a passage defined within the riser duct through which a particulate fluid mixture produced by the excavation can flow up the riser duct and into an interior of the submersible housing, and a sample container disposed within the submersible housing for collecting ore from the particulate fluid mixture received in the submersible housing. | 09-03-2009 |
Haleh Ahmadian, Solrod Strand DK
| Patent application number | Description | Published |
|---|---|---|
| 20080207880 | Reduction of the Content of Protein Contaminents in Compositions Comprising a Vitamin K-Dependent Protein of Interest - The present invention relates to Vitamin K-dependent protein compositions having a very low, or negligible, content of protein contaminants. The present invention also relates to method applicable in the preparation of such Vitamin K-dependent protein compositions. Such methods may either be used alone or in sequential combination with the purpose of reducing the relative content of protein contaminants. The present invention is particularly relevant in the preparation of compositions of coagulation factors selected from Factor X polypeptides (FX/FXa), Factor IX polypeptides (FIX/FIXa), Factor VII polypeptides (FVII/FVIIa), and the anticoagulant Protein C, in particular Factor VII polypeptides. | 08-28-2008 |
| 20080268521 | Purification of Coagulation Factor VII Polypeptides - An improved method for producing FVII and FVIIa polypeptides is disclosed. Also provided are FVII and FVIIa compositions having low contents of auto-degradation products. | 10-30-2008 |
| 20110065937 | METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM - The present invention relates to a novel method for the preparation of diol intermediates having the formula (II) and/or the opposite enantiomer of an acylated diol having the formula (IV) useful for the preparation of escitalopram involving selective enzymatic acylation or deacylation. | 03-17-2011 |
| 20110065938 | METHOD FOR THE PREPARATION OF ESCITALOPRAM - A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as Chiralpak™ AD or Chiralcel™ OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided. | 03-17-2011 |
Hossein Ahmadian, Newcastle Upon Tyne GB
| Patent application number | Description | Published |
|---|---|---|
| 20150038395 | METHOD OF MAKING DETERGENT COMPOSITIONS COMPRISING POLYMERS - A process of making a granular detergent composition comprising the steps of: | 02-05-2015 |
| 20150038396 | METHOD OF MAKING GRANULAR DETERGENT COMPOSITIONS COMPRISING SURFACTANTS - A process of making a granular detergent composition comprising the steps of: | 02-05-2015 |
| 20150038397 | METHOD OF MAKING GRANULAR DETERGENT COMPOSITIONS COMPRISING POLYMERS - A process of making a granular detergent composition comprising the steps of: | 02-05-2015 |
Mahmoud Ahmadian, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20150370716 | System and Method to Enable Dynamic Changes to Virtual Disk Stripe Element Sizes on a Storage Controller - A storage controller includes a storage controller memory to store virtual disk metadata including an original stripe size (OSS) field and a logical stripe size (LSS) field, and a cache memory having an OSS buffer and a LSS buffer. The storage controller stores a first block size in the OSS field, configures a RAID array to provide storage blocks of the first block size based on the OSS field, stores a second block size in the LSS field, receives a first data transaction that includes a first data block of the second block size based upon the LSS field, maps the first data block from the second block size to the first block size, and executes the first data transaction on the RAID array using the first block size. | 12-24-2015 |
Mahmoud Ahmadian, Pflugerville, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080215912 | System and Method for Raid Recovery Arbitration in Shared Disk Applications - A RAID controller is provided for each host sharing a RAID. Each RAID controller can determine whether another host is sharing the RAID and assume a master or slave status with respect to rebuild operations for the shared disk. The master controller may then manage any rebuild operations on rebuild disks within the RAID. | 09-04-2008 |
Mahmoud B. Ahmadian, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120047264 | SYSTEM AND METHOD TO DYNAMICALLY ALLOCATE ELECTRONIC MAILBOXES - Systems and methods for balancing electronic mailboxes among databases communicatively coupled to an information handling system are disclosed. A method may include comparing an actual utilization values for a first database to a threshold utilization value for the first database and, depending upon the results, identifying the first database as over-utilized. The method may also include comparing an actual utilization values for a second database to a threshold utilization value for the second database and, depending upon the results, identifying the second database as under-utilized. The method may further include comparing a threshold usage value of a first electronic mailbox stored in the first database to an upper threshold usage value for the first electronic mailbox and, depending upon the results, identifying the first electronic mailbox as heavily-utilized. The method may also include moving the heavily-utilized electronic mailbox to the second database. | 02-23-2012 |
Mahmoud B. Ahmadian, Pflugerville, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20150200911 | CONSISTENT BINDING OF SHARED STORAGE ACROSS CLUSTERED SERVERS - An information handling system includes first and second nodes and a storage enclosure. The nodes share access to the storage enclosure. The nodes bind a logical unit number (LUN) in the storage enclosure consistently regardless of an order in which the two devices access the LUN. The system further preferably includes a switch between the nodes and the storage enclosure wherein multiple paths exist between a node and the storage enclosure. The storage enclosure preferably includes first and second storage processors and multiple ports per processor. The first node preferably includes first and second host bus adapters. The first host bus adapter preferably connects the node to a first of the switches and the second host bus adapter connects the node to a second of the switches. The system preferably includes multiple paths between the first node and a LUN in the storage enclosure. | 07-16-2015 |
Maryam Ahmadian, Berkeley, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140147431 | Compositions and Methods for Modulating Desnutrin-Mediated Adipocyte Lipolysis - The present disclosure provides methods of converting white adipose tissue to brown adipose tissue in an individual, generally involving modulating desnutrin-mediated lipolysis in adipocytes in the individual. The present disclosure further provides methods for treating obesity. The present disclosure further provides methods of identifying an agent that increases the level and/or activity of desnutrin in an adipocyte. | 05-29-2014 |
Mehdi Ahmadian, Blacksburg, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20100182613 | DOPPLER SENSOR FOR THE DERIVATION OF TORSIONAL SLIP, FRICTION AND RELATED PARAMETERS - An optical method and apparatus are described for the measurement of properties of a travel vehicle or a travel surface upon which the travel vehicle travels, which includes providing an incident light from a light source to the travel surface, collecting light reflected from the travel surface, determining a surface induced Doppler shift from the incident and collected light and determining at least one of a motion property of the travel vehicle and a surface property of the travel surface based on the determined surface induced Doppler shift. | 07-22-2010 |
Mohammad Ahmadian, Carlsbad, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100105134 | NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF - The present disclosure provides RNA molecules, for example, meroduplex ribonucleic acid molecules (mdRNA), and blunt ended double-stranded ribonucleic acid molecules capable of decreasing or silencing expression of a target gene. An mdRNA of this disclosure comprises at least three strands that combine to form at least two non-overlapping double-stranded regions separated by a nick or gap wherein one strand is complementary to a target mRNA. Also provided are methods of decreasing expression of a target gene in a cell or in a subject to treat a disease or condition associated with the target gene. | 04-29-2010 |
| 20110224148 | CARBOHYDRATE-POLYAMINO ACID-DRUG CONJUGATES - Compositions that include a polymer conjugate and glucosamine operatively associated with the polymer conjugate, wherein the polymer conjugate includes a first drug, are described herein. Also disclosed herein are methods of using such compositions to treat, ameliorate, or diagnose a disease or condition such as cancer. | 09-15-2011 |
| 20130017249 | COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY - Here described are compounds consisting of the structure | 01-17-2013 |
| 20130022665 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS - Here described are compounds of formula I: | 01-24-2013 |
| 20130071467 | RETINOID-LIPOSOMES FOR TREATING FIBROSIS - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH1_2 (SEQ ID NOS: 60 and 127), SERPINH1_45a (SEQ ID NOS: 98 and 165), and SERPINH1_51 (SEQ ID NOS: 101 and 168), and drug carrier comprising a mixture of a retinoid and a lipid vesicle, and methods of using these pharmaceutical compositions to treat a disease associated with hsp47 expression, including fibrosis. | 03-21-2013 |
| 20130071478 | RETINOID-LIPOSOMES FOR ENHANCING MODULATION OF HSP47 EXPRESSION - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH | 03-21-2013 |
| 20130171127 | COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE - The present invention relates to a pharmaceutical composition and a method for regenerating normal tissue from fibrotic tissue, the pharmaceutical composition and the method employing a collagen-reducing substance. In accordance with the present invention, normal tissue can be therapeutically regenerated from fibrotic tissue. | 07-04-2013 |
| 20130171240 | DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS - Disclosed is a stellate cell-specific drug carrier comprising a stellate cell-specific amount of a retinoid derivative and/or a vitamin A analogue, and a drug carrier component other than the retinoid derivative and/or a vitamin A analogue. Also disclosed in a medicine comprising the stellate cell-specific drug carrier, and a drug in an amount effective for controlling the activity or growth of stellate cells. | 07-04-2013 |
| 20130210744 | TARGETING AGENT FOR CANCER CELL OR CANCER-ASSOCIATED FIBROBLAST - Disclosed are a novel therapeutic agent and a novel treatment method for cancer. Specifically disclosed are: a targeting agent for a cell selected from the group consisting of a cancer cell and a cancer-associated fibroblast, which comprises a retinoid and/or derivative thereof; a substance delivery carrier for the cell, which comprises the targeting agent; an anti-cancer composition utilizing the targeting agent or the carrier; an anticancer-associated fibroblast composition; and a method for treatment of cancer. | 08-15-2013 |
| 20130330401 | LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS - The description is directed to ionizable lipids useful for enhancing the delivery of therapeutic agents in liposomes. | 12-12-2013 |
| 20140294934 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS - Here described are compounds of formula I: | 10-02-2014 |
| 20140356413 | RETINOID-LIPOSOMES FOR TREATING FIBROSIS - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH1_2 (SEQ ID NOS: 60 and 127), SERPINH1_45a (SEQ ID NOS: 98 and 165), and SERPINH1_51 (SEQ ID NOS: 101 and 168), and drug carrier comprising a mixture of a retinoid and a lipid vesicle, and methods of using these pharmaceutical compositions to treat a disease associated with hsp47 espresssion, including fibrosis. | 12-04-2014 |
Shaun S. Ahmadian, Rolling Hills Estates, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120092169 | METHOD OF ASSESSING HUMAN FALL RISK USING MOBILE SYSTEMS - A method for determining the motive instability of an individual using foot pressure, foot speed and foot direction data collected from sensors on shoes. The sensed data is used to determine the minimum number and the placement of pressure sensors in the shoe. The data from the sensors is processed to extract spatial and temporal parameters as desired. The data is grouped into segments based on a segmentation rule. The trend in each segment is determined. The variability of the trend in each segment is determined. The risk of fall is computed on the basis of the trend and variance. The computation is adjustable by emphasizing certain parameters in order to tailor the instability assessment to a specific individual. | 04-19-2012 |